Citation 170133

HALL,IH: LEE,KH: WILLIAMS JR,WL: KIMURA,T: HIRAYAMA,T:. (1980). ANTITUMOR AGENTS.XLI: EFFECTS OF EUPAFORMOSANIN ON NUCLEIC ACID PROTEIN AND ANAEROBIC AND AEROBIC GLYCOLYTIC METABOLISM OF EHRLICH ASCITES CELLS.. 69()

Citation Details

Title	ANTITUMOR AGENTS.XLI: EFFECTS OF EUPAFORMOSANIN ON NUCLEIC ACID PROTEIN AND ANAEROBIC AND AEROBIC GLYCOLYTIC METABOLISM OF EHRLICH ASCITES CELLS.
Authors	HALL,IH: LEE,KH: WILLIAMS JR,WL: KIMURA,T: HIRAYAMA,T:
Year	1980
Volume	69
Issue

Summary

Year: 1980

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	EUPAFORMOSANIN	ACTIVE
2	SUCCINATE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFORMOSANIN	ACTIVE
3	ALPHA-KETOGLUTARIC OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFORMOSANIN	ACTIVE
4	ATP-ASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFORMOSANIN	INACTIVE
5	ATP-ASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFORMOSANIN	INACTIVE
6	SUCCINATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFORMOSANIN	ACTIVE
7	MALATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFORMOSANIN	ACTIVE
8	FRUCTOSE DIPHOSPHATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFORMOSANIN	ACTIVE
9	GLYCERALDEHYDE PHOSPHATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFORMOSANIN	ACTIVE
10	HEXOKINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFORMOSANIN	WEAK ACTIVITY
11	PHOSPHOFRUCTOKINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFORMOSANIN	ACTIVE
12	GLUCOSE-6-PHOSPHATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFORMOSANIN	STRONG ACTIVITY
13	GLUCOSE-6-PHOSPHATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFORMOSANIN	ACTIVE
14	CATHEPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	INACTIVE
15	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	INACTIVE
16	DEOXYRIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	ACTIVE
17	CYCLIC AMP STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	ACTIVE
18	RIBONUCLEOTIDE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	WEAK ACTIVITY
19	ADENOSYL METHIONINE TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	EQUIVOCAL
20	DIHYDROFOLATE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	INACTIVE
21	THYMIDYLATE DIPHOSPHATE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	INACTIVE
22	THYMIDINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	INACTIVE
23	CHOLESTEROL SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	ACTIVE
24	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	INACTIVE
25	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	ACTIVE
26	THYMIDYLATE MONOPHOSPHATE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	WEAK ACTIVITY
27	DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	ACTIVE
28	THYMIDYLATE SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	ACTIVE
29	PURINE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	ACTIVE
30	CARBAMYL PHOSPHATE SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	ACTIVE
31	ASPARTATE CARBAMATE TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	ACTIVE
32	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	EUPAFORMOSANIN	ACTIVE

Citation 170133

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1